Personalized Medicine in Action: The Shift from One-Size-Fits-All to Mutation-Specific Therapies in the Duchenne Muscular Dystrophy Market Forecast.
The Duchenne Muscular Dystrophy (DMD) market has transitioned irrevocably toward a model of personalized medicine, moving away from generalized supportive care. This fundamental shift is dictated by the genetic nature of DMD, which is caused by various distinct mutations within the large dystrophin gene. The market is now stratified by mutation type, with several therapies—primarily...
0 Commentaires 0 Parts 347 Vue 0 Aperçu